Interní Med. 2006; 8(11): 476-480 [Klin Farmakol Farm. 2006;20(1):19-22]

Treatment of diabetic neuropathy

MUDr. Jindřich Olšovský
II. interní klinika FN u sv. Anny LF MU, Brno

The author presents an overview of management issues in diabetic neuropathy. Based on classification, clinical manifestations and diagnosis, he outlines the therapeutic options of diabetic neuropathy. These include both causal and symptomatic approaches.

Keywords: Key words: diabetic neuropathy, sensitive, motor and vegetative nerve fibres, symmetric, focal and combined types of diabetic neuropathy, causal and symptomatic therapy.

Published: March 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Olšovský J. Treatment of diabetic neuropathy. Interní Med. 2006;8(11):476-480.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Diabetes Association: American Academy of Neurology: Consensus statement report and reccomendations of the San Antonio conference on diabetic neuropathy. Diabetes Care II 1998; 592-597.
    2. Boulton AMJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy Diabetic Med 1998; 15: 508-514. Go to original source... Go to PubMed...
    3. DCCT Trial Researcg Group: The effect of intenzive diabetes therapy on the development and progression of neuropathy Ann int. med. 1995; 122: 561-568. Go to original source... Go to PubMed...
    4. Ewing DJ, Martyn CHN, Young RJ a spol: The value of cardiovascular autonomic function test: 10 years experience in diabetes Diabetes Care 1985; 8: 491-498. Go to original source... Go to PubMed...
    5. Gilron I, Bailey JM, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324-1334. Go to original source... Go to PubMed...
    6. Krahulec B. Diabetická neuropatie in Všeobecná a klinická endokrinologie kolektiv autorů, AEP Bratislava 2004; 676-697.
    7. Olšovský J. Diabetická neuropatie in Perušičová Trendy soudobé diabetologie svazek 6, Praha, Galén 2002; 85-98.
    8. Olšovský J. Diabetická neuropatie, Postgraduální medicína, 2005; 7, 4: 437-441.
    9. Rušavý Z. Diabetická polyneuropatie in Diabetická noha, Praha, Galén 1998; 26-39.
    10. Sima AA, Calvani M, Mehra M, et al. Acetyl-L-carnitine improves pain, nerve regeneration and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomised, placebo-controlled trials, Diabetes Care 2005; 28: 89-94. Go to original source... Go to PubMed...
    11. Syndrom diabetické nohy: mezinárodní konsenzus vypracovaný skupinou pro syndrom diabetické nohy, Galén Praha 2000.
    12. Vondrová H, Szántó J. Cukrovka a poruchy nervového systému, Praha, Grada 1999.
    13. Ward JD. Diabetic Neuropathy, International Textbook of Diabetes Mellitus, West Sussex England: John Wiley, 1992; 1385-1414.
    14. Ziegler D. Diabetic cardiovascular autonomic neuropathy In Diabetic neuropathy (ed. Boulton AJM) Aventis 2001; 140-169.
    15. Ziegler D. Diabetic peripheral neuropathy In diabetes and cardiovascular risk (ed. Ritz E) Aventis 2002; 244-287.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.